by Silvia Prades | Jul 30, 2024 | News Articles
Nissan Chemical Corporation and Sanwa Kagaku Kenkyusho Co., Ltd., two Japanese companies, have announced they recently co-created an antisense oligonucleotide (ASO) for DRPLA. ASOs have emerged as a promising strategy for various neurodegenerative conditions,...
by Silvia Prades | Jul 3, 2024 | News Articles
Junko Shiozawa, Advisory Board Member to CureDRPLA, has created a community of Japanese families affected by DRPLA. They offer peer support to each other and host online meetings. Since DRPLA is more common in Japan, it was important for us to create a Japanese...
by Silvia Prades | Jun 10, 2024 | News Articles
CureDRPLA has been funding research that aims to better understand DRPLA symptoms and how this condition develops over time, such as the DRPLA Natural History and Biomarkers Study. While such research projects are essential for advancing research towards clinical...
by Silvia Prades | May 28, 2024 | Announcements
ICAR, largest gathering of ataxia scientists and medical professionals, will take place in London, November 12-15. CureDRPLA team members will be there, along with scientists working on DRPLA who will present their latest research.
by Silvia Prades | May 28, 2024 | News Articles, Uncategorized
This announcement was initially published on our website on February 12, 2024. You can find a pdf version of the announcement here. Dear DRPLA community, Since we established CureDRPLA in 2019, our mission has been to connect families, physicians and scientific...
Recent Comments